Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow
Category: News
Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis
The project will assist researchers and companies in training the technology for healthcare settings
The fatal, progressive neurological condition currently affects around 5,000 people in the UK
The third most common and serious form of cancer affects over 43,000 people every year in the UK
The progressive neurodegenerative disease is estimated to affect 24 million people globally
The genetic condition affects one in 279 people in England and significantly increases cancer risk
Two out of three people with the neurodegenerative condition experienced delirium in hospital
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m